Cargando…
NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
Prostate cancer stem cells (CSCs) are defined by their extensive self-renewal, differentiation and tumor initiation properties. It is now clear that CSCs are involved in tumor growth and recurrence, and resistance to conventional treatments. The sonic hedgehog (Shh) pathway has a crucial role in ste...
Autores principales: | Nanta, R, Kumar, D, Meeker, D, Rodova, M, Van Veldhuizen, P J, Shankar, S, Srivastava, R K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641359/ https://www.ncbi.nlm.nih.gov/pubmed/23567619 http://dx.doi.org/10.1038/oncsis.2013.5 |
Ejemplares similares
-
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
por: D'Amato, C, et al.
Publicado: (2014) -
NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
por: Jalili, Ahmad, et al.
Publicado: (2013) -
Correction: NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
por: Jalili, Ahmad, et al.
Publicado: (2013) -
Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011) -
Comparison of biological features between severely immuno-deficient
NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid
Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019)